about
The retinal proteome in experimental diabetic retinopathy: up-regulation of crystallins and reversal by systemic and periocular insulinDifferential roles of hyperglycemia and hypoinsulinemia in diabetes induced retinal cell death: evidence for retinal insulin resistanceDiabetic retinopathy: seeing beyond glucose-induced microvascular disease.Light scatter causes the grayness of detached retinas: implications for vision loss in retinal detachment.mTORC1-independent reduction of retinal protein synthesis in type 1 diabetes.Differential reduction in corneal nerve fiber length in patients with type 1 or type 2 diabetes mellitus.Diabetic Retinopathy: A Position Statement by the American Diabetes Association.Diabetic retinopathy: more than meets the eye.Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structureInsulin signaling in retinal neurons is regulated within cholesterol-enriched membrane microdomains.The Effects of Diabetic Retinopathy and Pan-Retinal Photocoagulation on Photoreceptor Cell Function as Assessed by Dark AdaptometryPhosphatase control of 4E-BP1 phosphorylation state is central for glycolytic regulation of retinal protein synthesis.Subconjunctivally Implanted Hydrogels for Sustained Insulin Release to Reduce Retinal Cell Apoptosis in Diabetic RatsPredicting development of proliferative diabetic retinopathyGlucose variability and inner retinal sensory neuropathy in persons with type 1 diabetes mellitus.Nanoliposomal minocycline for ocular drug deliveryBioelectric impact of pathological angiogenesis on vascular function.Impaired coronary and retinal vasomotor function to hyperoxia in Individuals with Type 2 diabetes.Neuroprotection for diabetic retinopathy.An integrated approach to diabetic retinopathy research.Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment.Incidence and Risk Factors for Developing Diabetic Retinopathy among Youths with Type 1 or Type 2 Diabetes throughout the United States.Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in mild to moderate nonproliferative diabetic retinopathy: a randomized proof-of-concept clinical trial.Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in patients with severe nonproliferative or non-high-risk proliferative diabetic retinopathy: a randomized clinical trial.Retinal Failure in Diabetes: a Feature of Retinal Sensory Neuropathy.Diabetic Retinopathy and Diabetic Macular Edema.Impact of diagnosing diabetic complications on future hemoglobin A1c levels.Insulin-like growth factor 1 rescues R28 retinal neurons from apoptotic death through ERK-mediated BimEL phosphorylation independent of Akt.The neurovascular unit and the pathophysiologic basis of diabetic retinopathy.Ophthalmic Screening Patterns Among Youths With Diabetes Enrolled in a Large US Managed Care Network.Rates of Vitrectomy among Enrollees in a United States Managed Care Network, 2001-2012.Occludin S490 Phosphorylation Regulates Vascular Endothelial Growth Factor-Induced Retinal Neovascularization.Effect of IL-1beta on survival and energy metabolism of R28 and RGC-5 retinal neurons.Diabetic macular oedema and visual loss: relationship to location, severity and duration.Quantification of fundus autofluorescence to detect disease severity in nonexudative age-related macular degeneration.Excessive hexosamines block the neuroprotective effect of insulin and induce apoptosis in retinal neurons.Insulin rescues retinal neurons from apoptosis by a phosphatidylinositol 3-kinase/Akt-mediated mechanism that reduces the activation of caspase-3.Physiological transport properties of cultured retinal microvascular endothelial cell monolayers.Histamine H1 receptors mediate increased blood-retinal barrier permeability in experimental diabetes.Antihistamines reverse blood-ocular barrier breakdown in experimental diabetes.
P50
Q28388205-021C6C35-B3F6-4BB9-B284-E2A42A8533F0Q28743462-DEABA81D-2ED8-42A5-A077-4A473D2C03DDQ30356505-5FAD9F41-63E6-4DDA-AA4F-0002E9A4BE2BQ31149634-55DEE7B9-28C8-426B-8BFA-BA1C83A273AAQ34077374-F4200135-94B0-442F-9EAF-A6015A9D055CQ34096711-8A9217EB-6517-4F5C-93C2-088E1DA63E56Q34551730-484A14B6-055C-437C-BC65-204D8E5B4843Q35036623-BD4FEDB9-F642-498D-960E-89A46E1EB4E9Q35544948-B1148DE0-5D7D-40EA-A02E-EB92AC7B81CFQ35756442-7544727C-9FA3-4F82-ACB7-2017FA66602CQ35902518-145A208A-DE87-43A5-961F-3FF6B72486C7Q36066571-2818A9B7-648B-463C-9BD1-31639CCF84DDQ36380233-1003CECD-0106-42FF-9326-10D6982F52DDQ36868163-48055A65-7F1A-42DA-AF17-F146D4AF7E8AQ37000730-65964ED9-964C-456D-B75E-74FFB26D1390Q37145338-7519BC15-63D0-4FE9-9872-B19ABFFE9725Q37258464-EF22BCBA-36C7-4A48-A616-5F174993BB0AQ37334645-78C1036A-806C-4173-B20A-67E22E1B50C4Q37507293-7168C4C9-62DB-44C3-B776-C3E42C92E7FDQ37841990-31C5D118-B083-4B66-BF46-7FA16EF45297Q38199730-F0768565-A819-44E3-B101-67BD2CD7520BQ38404089-639B61E6-704C-47F4-ADEC-C3D3BC7E3830Q38427709-30A9CDED-2F24-4316-86DE-D5ACD2F26755Q38434860-1139F949-7467-4407-AB7E-4A0C1222439DQ38605095-E8334FD1-5986-412F-94FB-A4263AE7B868Q38616344-F66D7758-5833-4722-B500-EF18A264B91FQ38690843-4AC5808D-AEF4-49A5-824B-D8FEEEBBEA2BQ38752597-B6D57CEB-90B5-4CD5-9125-22250CF9C92AQ38796704-6C614AE0-3ED3-47F6-A6C6-A7BBF0EC7D86Q38882724-8E22F704-DF8C-44B6-9F54-393F38411752Q38922875-F4FA8755-E08B-4EAA-AEB0-344DA256E694Q39595301-B015227E-E9E9-4C3A-AD93-67F86E235425Q39911720-468E875B-600D-40FD-B698-6B24D27153CBQ39940124-57AE5D21-FC6B-42FA-8CA9-A970E319E06AQ40119100-99751179-5274-45B6-B557-0E1ED31BFF09Q40780090-EBE91B95-E75C-4AA8-8D44-ABE2F5A9DE7BQ40793937-6A698FA8-71E7-4C39-B352-72A2FC7B90FCQ40886269-6B6E8F4D-C3D9-45EE-A038-87FE1A835490Q41264974-E4A9958E-F514-488D-B7BC-6EC69D79E0E7Q41346880-7399984F-36AD-4E8E-AB4C-69D44BC9AA1A
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Thomas W. Gardner
@ast
Thomas W. Gardner
@en
Thomas W. Gardner
@es
Thomas W. Gardner
@sl
type
label
Thomas W. Gardner
@ast
Thomas W. Gardner
@en
Thomas W. Gardner
@es
Thomas W. Gardner
@sl
prefLabel
Thomas W. Gardner
@ast
Thomas W. Gardner
@en
Thomas W. Gardner
@es
Thomas W. Gardner
@sl
P106
P1153
7201863965
P21
P31
P496
0000-0002-5112-5810